Questionnaires Assessing the Quality of Life of Patients Treated for Coronary Heart Disease
Questionnaires Assessing the Quality of Life of Patients Treated for Coronary Heart Disease
Cardiovascular disease remains the leading cause of death in Europe and worldwide. In 2014,
 they led to more than 4 million deaths in Europe, and coronary heart disease alone accounts
 for nearly 1.8 million deaths, or 20% of all deaths in Europe. However, mortality from
 cardiovascular disease and, especially, coronary heart disease has declined in recent
 decades. This has been made possible by improving the quality of care provided to patients.
 Several studies have been conducted to demonstrate this improvement in the quality of care,
 but they mainly measure the functional results of treatment, morbidity and mortality,
 survival and prolongation of life.

 However, patient-centered outcomes such as health-related quality of life outcomes (such as
 mental function, ability to resume activities of daily living, social relationship) are also
 considered important outcomes in the management and monitoring of these diseases. Some
 studies have shown that, even when other risks factors are controlled, a poor quality of life
 related to health is a prediction factor for morbidity and mortality in patients with
 coronary artery disease.

 Some studies have suggested that health-related quality of life should be strongly associated
 with lifestyle, co-morbidities, and mental function.

 Some factors have been identified as factors that may affect the quality of life in patients
 with coronary artery disease, including depression, anxiety, dyspnea and angina pectoris.
 Depression and anxiety were negatively associated with health-related quality of life in
 patients with cardiovascular disease. As for dyspnea, it has been shown that in stable
 patients who have had a myocardial infarction, its increase at 1 month after initiation of
 treatment is strongly associated with a decrease in the quality of life and with an increased
 risk of re-hospitalization and death. It is therefore important to measure these factors when
 the quality of life is assessed in patients with coronary heart disease.

 The importance of assessing quality of life is that the clinician and the patient often have
 different concerns: what the clinician considers to be a "successful procedure" is not always
 considered as such by the patient. Results related to quality of life (results rarely
 evaluated) are among the results that really interest the patient. Indeed, many patients
 consider the quality of additional years of life acquired as important as the lifespan, so
 the goal of today's medicine is to improve the quantity and quality of life of the additional
 years of life acquired. To ensure this improvement, the assessment of health-related quality
 of life should be integrated into the daily clinical practice of coronary heart disease
 management.

 The objective of our study is to evaluate the feasibility of this practice throughout the
 traject of care, by using several standardized questionnaires.
Inclusion Criteria:

 Confirmed coronary disease

 Exclusion Criteria:

 Emergencies, patients lost to follow-up.